D. Snodin

A. Renwick, D. Snodin, A. Roberts, 2000, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

The Structures of the Trihydroxyflavans from the Acid-catalyzed Rearrangement and Dimerization of 3-Carene-2,5-dione

D. Snodin, I. V. Still, 1972 .

Elusive Impurities—Evidence versus Hypothesis. Technical and Regulatory Update on Alkyl Sulfonates in Sulfonic Acid Salts

D. Snodin, 2019, Organic Process Research & Development.

Control and analysis of hydrazine, hydrazides and hydrazones--genotoxic impurities in active pharmaceutical ingredients (APIs) and drug products.

D. Elder, D. Snodin, D P Elder, 2011, Journal of pharmaceutical and biomedical analysis.

Acceptance criteria for levels of hydrazine in substances for pharmaceutical use and analytical methods for its determination.

D. Snodin, T. Kean, G. Skellern, 2006, Pharmeuropa scientific notes.

Understanding and Applying Regulatory Guidance on the Nonclinical Development of Biotechnology-Derived Pharmaceuticals

D. Snodin, P. Ryle, David J. Snodin, 2012, BioDrugs.

Mutagenic Alkyl-Sulfonate Impurities in Sulfonic Acid Salts: Reviewing the Evidence and Challenging Regulatory Perceptions

D. Snodin, A. Teasdale, 2015 .

The reactions of aryloxysulphoxonium salts with amines and other nucleophiles

D. Snodin, G. Stevens, M. Whiting, 1978 .

Analytical approaches for the detection of epoxides and hydroperoxides in active pharmaceutical ingredients, drug products and herbals.

D. Elder, D. Snodin, D P Elder, 2010, Journal of pharmaceutical and biomedical analysis.

Residues of genotoxic alkyl mesylates in mesylate salt drug substances: real or imaginary problems?

D. Snodin, David J Snodin, 2006, Regulatory toxicology and pharmacology : RTP.

The metabolism of beef tallow sucrose esters in rat and man.

D. Snodin, J. W. Daniel, H. F. Jones, 1979, Food and cosmetics toxicology.

Setting Limits for Genotoxic Impurities in Drug Substances

D. Kirkland, D. Snodin, 2012, International Journal of Pharmaceutical Medicine.

Setting limits for genotoxic impurities in drug substances: Threshold-based and pragmatic approaches

D. Kirkland, D. Snodin, 2004 .

Verticillium lecanii. Allergological and toxicological studies on work exposed personnel.

D. Snodin, K. Eaton, T. J. Hennessy, 1986, The Annals of occupational hygiene.

3 Toxicology and Adverse Drug Reactions

D. Snodin, 2004 .

Implementation of ICH S6: EU Perspective

D. Snodin, P. Ryle, 2010 .

A Primer for Pharmaceutical Process Development Chemists and Analysts in Relation to Impurities Perceived to Be Mutagenic or “Genotoxic”

D. Snodin, 2020 .

Mutagenic impurities in pharmaceuticals: a critique of the derivation of the cancer TTC (Threshold of Toxicological Concern) and recommendations for structural-class-based limits.

D. Snodin, David J Snodin, Sean D McCrossen, 2013, Regulatory toxicology and pharmacology : RTP.

Genotoxic Impurities: A Regulatory Toxicology Commentary on Recent Articles in Organic Process Research & Development

D. Snodin, 2011 .

Short commentary on NDMA (N‐nitrosodimethylamine) contamination of valsartan products

D. Elder, D. Snodin, 2019, Regulatory toxicology and pharmacology : RTP.

Mutagenic impurities in pharmaceuticals: A critical assessment of the cohort of concern with a focus on N-nitrosamines.

D. Snodin, 2023, Regulatory toxicology and pharmacology : RTP.

Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: is aromatic N-oxide a structural alert for predicting DNA-reactive mutagenicity?*

Naomi L Kruhlak, Lidiya Stavitskaya, Alexander Amberg, 2018, Mutagenesis.

Regulatory risk assessments: Is there a need to reduce uncertainty and enhance robustness? Update on propylparaben in relation to its EU regulatory status

D. Snodin, 2017, Human & experimental toxicology.

Potentially Mutagenic Impurities (PMIs): Optimizing Toxicological and Analytical Assessments

D. Snodin, David J. Snodin, 2014 .

An EU perspective on the use of in vitro methods in regulatory pharmaceutical toxicology.

D. Snodin, 2002, Toxicology letters.

Safety evaluation of thaumatin (Talin protein).

D. Snodin, K. Eaton, J. Higginbotham, 1983, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

Acceptable Intakes (AIs) for 11 Small molecule N-nitrosamines (NAs).

R. Weaver, A. Czich, D. Snodin, 2023, Regulatory toxicology and pharmacology : RTP.

Mechanisms of Nitrosamine Mutagenicity and Their Relationship to Rodent Carcinogenic Potency.

Krista L Dobo, A. Kalgutkar, A. Czich, 2024, Chemical research in toxicology.

Drug substances presented as sulfonic acid salts: overview of utility, safety and regulation

D. Elder, D. Snodin, 2009, The Journal of pharmacy and pharmacology.